{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11274976", "DateCompleted": {"Year": "2001", "Month": "04", "Day": "19"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "23"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0006-2952", "JournalIssue": {"Volume": "61", "Issue": "7", "PubDate": {"Year": "2001", "Month": "Apr", "Day": "01"}}, "Title": "Biochemical pharmacology", "ISOAbbreviation": "Biochem Pharmacol"}, "ArticleTitle": "Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activation.", "Pagination": {"StartPage": "903", "EndPage": "910", "MedlinePgn": "903-10"}, "Abstract": {"AbstractText": ["Excessive nitric oxide (NO) produced by inducible NO synthase (iNOS) acts as a causative regulator in various inflammatory disease states. Carpesium divaricatum has been used in Korean traditional herbal medicine for its antipyretic, analgesic, vermifugic, and anti-inflammatory properties. We investigated the molecular mechanism for the suppression of lipopolysaccharide/interferon-gamma (LPS/IFN-gamma)-induced NO production in RAW 264.7 macrophages by the sesquiterpene lactone 2beta,5-epoxy-5,10-dihydroxy-6alpha-angeloyloxy-9beta-isobutyloxy-germacran-8alpha,12-olide (C-1), which has been identified recently as a new compound from C. divaricatum. C-1 decreased NO production in LPS/IFN-gamma-stimulated RAW 264.7 cells in a concentration-dependent manner, with an IC50 of approximately 2.16 microM; however, it had no direct effect on the iNOS activity of fully LPS/IFN-gamma-stimulated RAW 264.7 cells. Furthermore, treatment with C-1 led to a decrease in iNOS protein and mRNA. These effects appear to be due to inhibition of nuclear factor-kappaB (NF-kappaB) activation through a mechanism involving stabilization of the NF-kappaB/inhibitor of the kappaB (I-kappaB) complex, since inhibition of NF-kappaB DNA binding activity by C-1 was accompanied by a parallel reduction of nuclear translocation of subunit p65 of NF-kappaB and I-kappaBalpha degradation. Taken together, the results suggest that the ability of C-1 to inhibit iNOS gene expression may be responsible, in part, for its anti-inflammatory effects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Sungkyunkwan University, 440-746, Suwon, South Korea."}], "Identifier": [], "LastName": "Kim", "ForeName": "E J", "Initials": "EJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jin", "ForeName": "H K", "Initials": "HK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Y K", "Initials": "YK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "H Y", "Initials": "HY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "S Y", "Initials": "SY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "K R", "Initials": "KR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zee", "ForeName": "O P", "Initials": "OP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Han", "ForeName": "J W", "Initials": "JW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "H W", "Initials": "HW"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biochem Pharmacol", "NlmUniqueID": "0101032", "ISSNLinking": "0006-2952"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "I-kappa B Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Nfkbia protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Nitrites"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "139874-52-5", "NameOfSubstance": "NF-KappaB Inhibitor alpha"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "82115-62-6", "NameOfSubstance": "Interferon-gamma"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nos2 protein, mouse"}, {"RegistryNumber": "EC 6.-", "NameOfSubstance": "Ligases"}, {"RegistryNumber": "EC 6.-", "NameOfSubstance": "guanosine 3',5'-polyphosphate synthetases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Biological Transport"}, {"QualifierName": [], "DescriptorName": "Catalysis"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Cell Nucleus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Enzyme Repression"}, {"QualifierName": [], "DescriptorName": "I-kappa B Proteins"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Interferon-gamma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Ligases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "NF-KappaB Inhibitor alpha"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["biosynthesis", "genetics", "metabolism"], "DescriptorName": "Nitric Oxide Synthase"}, {"QualifierName": [], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitrites"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["biosynthesis", "drug effects"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sesquiterpenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "3", "Day": "29", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "4", "Day": "21", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "3", "Day": "29", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11274976", "10.1016/s0006-2952(01)00538-x", "S000629520100538X"]}}], "PubmedBookArticle": []}